Brief Research Report
Published on 26 Sep 2019
Cyclophilin Inhibitor NV556 Reduces Fibrosis and Hepatocellular Carcinoma Development in Mice With Non-Alcoholic Steatohepatitis
in Gastrointestinal and Hepatic Pharmacology
- 5,389 views
- 17 citations
Brief Research Report
Published on 26 Sep 2019
in Gastrointestinal and Hepatic Pharmacology
Review
Published on 24 Sep 2019
in Gastrointestinal and Hepatic Pharmacology
Original Research
Published on 20 Sep 2019
in Gastrointestinal and Hepatic Pharmacology
Original Research
Published on 20 Sep 2019
in Gastrointestinal and Hepatic Pharmacology
Original Research
Published on 18 Sep 2019
in Gastrointestinal and Hepatic Pharmacology
Correction
Published on 18 Sep 2019
in Gastrointestinal and Hepatic Pharmacology
Original Research
Published on 13 Sep 2019
in Gastrointestinal and Hepatic Pharmacology
Original Research
Published on 12 Sep 2019
in Gastrointestinal and Hepatic Pharmacology
Original Research
Published on 16 Aug 2019
in Gastrointestinal and Hepatic Pharmacology
Original Research
Published on 15 Aug 2019
in Gastrointestinal and Hepatic Pharmacology
Original Research
Published on 02 Aug 2019
in Gastrointestinal and Hepatic Pharmacology
Review
Published on 29 Jul 2019
in Gastrointestinal and Hepatic Pharmacology
Review
Published on 26 Jul 2019
in Gastrointestinal and Hepatic Pharmacology
Review
Published on 23 Jul 2019
in Gastrointestinal and Hepatic Pharmacology
Original Research
Published on 19 Jul 2019
in Gastrointestinal and Hepatic Pharmacology
Original Research
Published on 04 Jul 2019
in Gastrointestinal and Hepatic Pharmacology